Technology News
Latest technology news and updates
Total: 300

Musk Says Tesla’s Next-Gen Optimus Will Be Made in Texas as Production Scales Up
Elon Musk announced that Tesla’s Optimus 4 humanoid robot will be produced in Texas with a substantial increase in output. The declaration signals a push from prototypes toward scaled manufacturing, carrying significant supply‑chain, competitive and regulatory implications for the robotics industry and Tesla’s business mix.

Tiny Fonts, Big Fees: How Mobile Apps Are Quietly Draining China’s Elderly of Pensions
A wave of mobile apps in China is using deceptive design and opaque billing to extract small, repeated payments from elderly users, often hiding the true price behind small, pale fonts, “free” insurance pitches and automatic subscription switches. Legal and platform gaps — including weak pre-listing reviews, disputed intermediary liability and limited refund pathways through app stores — make recovery difficult and keep these practices profitable.

A Young Programmer’s Sudden Death Puts China’s Tech Overtime Culture Under the Microscope
A 32-year-old manager at Shiyuan, Gao Guanghui, collapsed and died suddenly at home in late November. His widow says chronic overwork, a heavy workload after a transfer, and a company culture that rewarded long hours are key parts of the context; the employer has paid RMB390,000 but denies legal responsibility. The case highlights broader concerns about occupational health, overtime norms and employer accountability in China’s technology sector.

Huawei Launches Broad Lunar New Year Discount Drive — Price Cuts Across Phones and Devices Top ¥4,000
Huawei has announced a wide-ranging Lunar New Year promotion on its official site, cutting prices across phones and other devices with headline discounts stated to reach up to ¥4,000 when combining model reductions, trade-ins and finance offers. The campaign aims to boost short-term sales, clear inventory and reinforce Huawei’s device ecosystem amid tougher market conditions and fierce domestic competition.

Alibaba’s Cainiao Consolidates Autonomous-vehicle Arm with Jiushi Intelligent — A Step Toward Integrated, Data-driven Last-mile Logistics
A NetEase headline reports a strategic integration between Cainiao’s unmanned-vehicle arm and Jiushi Intelligent. Though the original post lacked detail, the move would fit a broader pattern of Chinese logistics platforms vertically integrating autonomy technology to cut costs, capture data and accelerate last-mile automation.

Red Envelopes as Weapons: China’s Tech Giants Gamble Big to Buy AI Users This Lunar New Year
China’s tech giants are reviving Lunar New Year cash giveaways to accelerate AI app adoption: Tencent’s Yuanbao will distribute 1 billion yuan, Baidu’s Wenxin 500 million yuan, and ByteDance is showcasing its cloud under the Spring Gala. The tactics expose a strategic split—consumer subsidies to buy attention versus infrastructure plays to win enterprise customers—and highlight the fragility of changing user habits with cash alone.

Alipay Issues Tap‑to‑Send 'Red Envelope' Card — A Physical Key to Fee‑Free Lunar New Year Gifting
Alipay launched a physical 'tap' red‑envelope card on Jan 29 that lets users send and receive digital red packets by tapping their phones, with zero fees. The card is a marketing and engagement play aimed at converting offline gifting rituals into sustained digital payments activity, while raising routine security and data‑privacy considerations.

MiniMax’s Music 2.5 Sparks Hong Kong AI Rally — Signal of China’s Shift from Model Hype to Vertical Commercialisation
MiniMax’s launch of Music 2.5 — a music-generation model with stronger structural control and vocal fidelity — triggered sharp gains in Hong Kong AI stocks, highlighting a market pivot toward application-ready AI. Combined with open-source and deployment-focused releases from other domestic players, the episode underscores a broader shift in China’s AI industry from model-size competition to vertical, engineering-led commercialisation.

OpenAI Quietly Building a Bot‑Free Social Network — With Biometric ID as a Cure or a Risk
OpenAI is developing a social network intended to be restricted to verified humans, using biometric checks such as Face ID or an iris scanner called World Orb. The plan seeks to tackle persistent bot problems that have plagued platforms like X but raises serious privacy, security and regulatory questions.

Yang Zhilin Steps Forward: Moon’s Dark Side Ships Kimi K2.5 to Buy Time Against DeepSeek
Moon’s Dark Side released Kimi K2.5 with founder Yang Zhilin personally presenting the incremental upgrade, signalling a strategic shift from parameter-led competition to engineering improvements focused on coding and agent orchestration. The release is a defensive, deliverable move to shore up market position ahead of an expected DeepSeek model launch and to buy time for a more substantive K3 upgrade.

China’s Kunlun Tiangong Aims to Build an ‘AI Spotify’ Abroad as Music Models Hit a 2026 Inflection Point
Kunlun Tiangong founder Zhou Yahui says the company’s Mureka V8 music model marks a 2026 inflection point for AI-composed music and plans to launch an overseas, Spotify-like AI music platform. The firm will avoid direct competition with China’s ByteDance and Tencent, collaborate domestically, and focus overseas on productising AI-generated music via creator tools, a consumer app and APIs. Zhou argues AI music and short-form AI dramas could be the first major categories disrupted by native AI platforms in the next 1–3 years.

From Thought to Motion: Why China’s Robotics Industry Is Betting on Brain–Computer Interfaces for Rehabilitation and Elder Care
Chinese robotics firms are prioritizing rehabilitation and eldercare as the first real markets for embodied intelligence, pairing non‑invasive brain–computer interfaces with exoskeletons to restore patient agency and create quantifiable training data. Industry players are addressing technical, data and integration challenges through consortiums and clinical partnerships, aiming to convert early prototypes into scalable clinical products over the next three to five years.